However, it is not well understood how controlling blood pressure affects levels of troponin I and whether the change in troponin I levels predicted the future risk of cardiovascular disease.

The rate of cardiac injury as determined by cTnI in this study was 19%. In trying to identify any factors that may contribute to an overestimation of cardiac injury, we consider the use of cTnI ...

The following is a summary of "Macrotroponin interference and association with cardiotoxicity in patients receiving cardiotoxic breast cancer therapy: a pilot study," published in the February 2025 ...

A bracelet-like device that measures levels of troponin-I in the blood could provide a more efficient way of detecting a heart attack, according to US researchers. The wearable developed by RCE ...

Solid Biosciences reported recent positive data in developing their gene therapy candidate SGT-003. The phase 1/2 INSPIRE DUCHENNE trial results demonstrated that SGT-003 showed an average ...

More information: Gyeo‐Re Han et al, Deep Learning‐Enhanced Chemiluminescence Vertical Flow Assay for High‐Sensitivity Cardiac Troponin I Testing, Small (2025). DOI: 10.1002/smll.202411585 ...

Troponin is shown in red (subunits not distinguished). Upon binding calcium, troponin moves tropomyosin away from the myosin-binding sites on actin (bottom), effectively unblocking it. Modified ...

Also, the timing of the troponin measurements may have had an affect, that is, by missing elevation or the peak of elevation in some patients. In addition, we speculate that the quantity of ...

Cardiac enzymes ― also known as cardiac biomarkers ― include myoglobin, troponin and creatine kinase. Historically, lactate dehydrogenase, or LDH, was also used but is non-specific.